AFP and hepatocellular carcinoma: For the full combination, especially in the early stage (BCLC 0 + A) HCC patients, the diagnostic Youden index of the combination was >96.5% with LR+ (all >26) and LR− (all = 0), which was much better than the diagnostic efficacy of both the AFP alone and the 3-miRNA panel.